Literature DB >> 16314534

Targeted deletion of integrin-linked kinase reveals a role in T-cell chemotaxis and survival.

Emerson Liu1, Sumita Sinha, Christine Williams, Marcoli Cyrille, Eric Heller, Scott B Snapper, Katia Georgopoulos, Rene St-Arnaud, Thomas Force, Shoukat Dedhar, Robert E Gerszten.   

Abstract

Integrin-linked kinase (ILK) is a serine/threonine kinase that is important in cell-matrix interactions and cell signaling. To examine the role of ILK in leukocyte trafficking and survival, we generated T cell-specific ILK knockouts by breeding ILK(flox/flox) mice to transgenic mice expressing Cre recombinase under control of the Lck proximal promoter. Thymic T cells from Lck-Cre(+)/ILK(flox/flox) mice had a marked reduction (>95%) in ILK protein levels. Thymic cellularity was comparable in 3- to 4-week-old mice, but a threefold diminution of thymic T cells became evident by 6 to 8 weeks of age in the T cell-specific ILK knockout mice due to increased cell death of double-positive (DP) T cells. Analysis of peripheral T cells by quantitative PCR and by breeding Lck-Cre(+)/ILK(flox/flox) mice to a YFP-transgenic reporter strain demonstrated an approximate 20-fold enrichment of ILK-competent cells, suggesting these cells have a competitive advantage in trafficking to and/or survival in peripheral lymphatic organs. We explored mechanisms related to altered cell trafficking and survival that might explain the decreases in thymic cellularity and enrichment for ILK-competent cells in the spleen and lymph nodes. We observed a >50% reduction in chemotaxis of ILK-deficient T cells to the chemokines CXCL12 (stromal cell-derived factor [SDF]-1alpha) and CCL19 (macrophage inflammatory protein [MIP]-3beta), as well as enhanced apoptosis of ILK-deficient cells upon stress. Signaling studies in ILK-deficient T cells demonstrated diminished phosphorylation of Akt on the activating phosphorylation site, Ser 473, and a concordant decrease in Akt kinase activity following stimulation with the chemokine SDF-1. Rac1 activation was also markedly diminished in ILK-deficient T cells following chemokine stimulation. These data extend the role of ILK to immune-cell trafficking and survival via modulation of Akt- and Rac-dependent substrates, and have implications for cell recruitment in both homeostatic and pathological processes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314534      PMCID: PMC1316981          DOI: 10.1128/MCB.25.24.11145-11155.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  32 in total

1.  Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration.

Authors:  T Sasaki; J Irie-Sasaki; R G Jones; A J Oliveira-dos-Santos; W L Stanford; B Bolon; A Wakeham; A Itie; D Bouchard; I Kozieradzki; N Joza; T W Mak; P S Ohashi; A Suzuki; J M Penninger
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

2.  Polarization of chemoattractant receptor signaling during neutrophil chemotaxis.

Authors:  G Servant; O D Weiner; P Herzmark; T Balla; J W Sedat; H R Bourne
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

Review 3.  Conditional control of gene expression in the mouse.

Authors:  M Lewandoski
Journal:  Nat Rev Genet       Date:  2001-10       Impact factor: 53.242

4.  Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction.

Authors:  Z Li; H Jiang; W Xie; Z Zhang; A V Smrcka; D Wu
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

5.  Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration.

Authors:  Y Fukui; O Hashimoto; T Sanui; T Oono; H Koga; M Abe; A Inayoshi; M Noda; M Oike; T Shirai; T Sasazuki
Journal:  Nature       Date:  2001-08-23       Impact factor: 49.962

Review 6.  Integrin-linked kinase: a cancer therapeutic target unique among its ILK.

Authors:  Gregory Hannigan; Armelle A Troussard; Shoukat Dedhar
Journal:  Nat Rev Cancer       Date:  2005-01       Impact factor: 60.716

7.  Integrin-linked kinase and PINCH: partners in regulation of cell-extracellular matrix interaction and signal transduction.

Authors:  C Wu
Journal:  J Cell Sci       Date:  1999-12       Impact factor: 5.285

8.  Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation.

Authors:  E Hirsch; V L Katanaev; C Garlanda; O Azzolino; L Pirola; L Silengo; S Sozzani; A Mantovani; F Altruda; M P Wymann
Journal:  Science       Date:  2000-02-11       Impact factor: 47.728

9.  Drosophila integrin-linked kinase is required at sites of integrin adhesion to link the cytoskeleton to the plasma membrane.

Authors:  C G Zervas; S L Gregory; N H Brown
Journal:  J Cell Biol       Date:  2001-03-05       Impact factor: 10.539

10.  Actopaxin, a new focal adhesion protein that binds paxillin LD motifs and actin and regulates cell adhesion.

Authors:  S N Nikolopoulos; C E Turner
Journal:  J Cell Biol       Date:  2000-12-25       Impact factor: 10.539

View more
  23 in total

1.  DRM02, a novel phosphodiesterase-4 inhibitor with cutaneous anti-inflammatory activity.

Authors:  David W C Hunt; Iordanka A Ivanova; Lina Dagnino
Journal:  Tissue Barriers       Date:  2020-06-01

2.  SDF-1α degrades whereas glycoprotein 120 upregulates Bcl-2 interacting mediator of death extralong isoform: implications for the development of T cell memory.

Authors:  Sergey A Trushin; Alberto A Carena; Gary D Bren; Stacey A Rizza; Xiangyang Dong; Roshini S Abraham; Andrew D Badley
Journal:  J Immunol       Date:  2012-07-16       Impact factor: 5.422

3.  CCR7/CCL21 migration on fibronectin is mediated by phospholipase Cgamma1 and ERK1/2 in primary T lymphocytes.

Authors:  Laura A Shannon; Psachal A Calloway; T Paul Welch; Charlotte M Vines
Journal:  J Biol Chem       Date:  2010-10-01       Impact factor: 5.157

4.  Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure.

Authors:  Donald E White; Pierre Coutu; Yan-Fen Shi; Jean-Claude Tardif; Stanley Nattel; René St Arnaud; Shoukat Dedhar; William J Muller
Journal:  Genes Dev       Date:  2006-09-01       Impact factor: 11.361

5.  Disruption of Rxra gene in thymocytes and T lymphocytes modestly alters lymphocyte frequencies, proliferation, survival and T helper type 1/type 2 balance.

Authors:  Charles B Stephensen; Alexander D Borowsky; Kevin C Kent Lloyd
Journal:  Immunology       Date:  2007-04-13       Impact factor: 7.397

6.  Aortic aneurysm generation in mice with targeted deletion of integrin-linked kinase in vascular smooth muscle cells.

Authors:  Dongxiao Shen; Jian Li; John J Lepore; Thomas J T Anderson; Sumita Sinha; Alexander Y Lin; Lan Cheng; Ethan David Cohen; Jesse D Roberts; Shoukat Dedhar; Michael S Parmacek; Robert E Gerszten
Journal:  Circ Res       Date:  2011-07-21       Impact factor: 17.367

7.  Integrin-linked kinase is a functional Mn2+-dependent protein kinase that regulates glycogen synthase kinase-3β (GSK-3beta) phosphorylation.

Authors:  Mykola Maydan; Paul C McDonald; Jasbinder Sanghera; Jun Yan; Charalampos Rallis; Sheena Pinchin; Gregory E Hannigan; Leonard J Foster; David Ish-Horowicz; Michael P Walsh; Shoukat Dedhar
Journal:  PLoS One       Date:  2010-08-23       Impact factor: 3.240

8.  Integrin-linked kinase interactions with ELMO2 modulate cell polarity.

Authors:  Ernest Ho; Tames Irvine; Gregory J A Vilk; Gilles Lajoie; Kodi S Ravichandran; Sudhir J A D'Souza; Lina Dagnino
Journal:  Mol Biol Cell       Date:  2009-05-13       Impact factor: 4.138

Review 9.  The ILK/PINCH/parvin complex: the kinase is dead, long live the pseudokinase!

Authors:  Sara A Wickström; Anika Lange; Eloi Montanez; Reinhard Fässler
Journal:  EMBO J       Date:  2009-12-24       Impact factor: 11.598

10.  Expression of integrin-linked kinase in the murine lens is consistent with its role in epithelial-mesenchymal transition of lens epithelial cells in vitro.

Authors:  Matt S Weaver; Natalie Toida; E Helene Sage
Journal:  Mol Vis       Date:  2007-05-14       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.